Impact of Prostate Cancer Multifocality on Its Biology and Treatment
- 1 May 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Endourology
- Vol. 24 (5), 799-804
- https://doi.org/10.1089/end.2009.0462
Abstract
Any focal therapy requires correct localization of the lesion; consequently, much effort is now devoted to accurate characterization of the spatial distribution of the tumor within the prostate. One of the greatest difficulties in the localization of prostate cancer is its frequent multifocality, but prostate cancer is unifocal in 13% to 43.7% of cases and unilateral in 19.2%. In cases of multifocality, it seems that the index tumor is the biologic driving force behind the malignant potential of prostate cancer. Not only is the Gleason score of the secondary nodes lower than that of the index node, but 80% of the secondary nodes are smaller than 0.5 cc and almost all extraprostatic extensions are associated with the largest cancers. While current evaluation with 12 to 18 core biopsies may be adequate to determine the index lesion, transperineal three-dimensional mapping biopsy of the prostate should be undertaken if greater accuracy is needed.Keywords
This publication has 40 references indexed in Scilit:
- Focal Therapy Will Be the Future Treatment Modality: The Motion “Con”European Urology Supplements, 2009
- Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate CancerEuropean Urology Supplements, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Preoperative Prediction of Unifocal, Unilateral, Margin-Negative, and Small Volume Prostate CancerUrology, 2008
- Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapyThe Prostate, 2008
- Multifocal T4 non-small cell lung cancer: a subset with improved prognosis?European Journal of Cardio-Thoracic Surgery, 2008
- Focal or Subtotal Therapy for Early Stage Prostate CancerCurrent Treatment Options in Oncology, 2007
- Multifocal and Multicentric Breast Cancer: Does Each Focus Matter?Journal of Clinical Oncology, 2005
- Early gastric carcinoma: spread and multicentricityGastric Cancer, 2002
- Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate CancerPublished by American Medical Association (AMA) ,1998